Immunovant, Inc.

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fra…

Biotechnology

US, New York [HQ]

Competitors · Subsidiaries · Locations

Context Analysis

Competitors · Subsidiaries · Locations

The Contextualizer is eligible to "contextualize" the market relationships of Immunovant, Inc.,
e.g. through tracking it's acquisitions, subsidiaries, offices, fabrics and competitors around the globe.

Tip: If you see a dot, it's always worth scrolling up so that the map enlarges and points on top of each other (e.g. NYC vs. Fort Lee) can be differentiated.

U.S. · Business Intelligence

The U.S. map and table tracks offices, fabrics, competitors and subsidiaries located in the United States.

Worldwide · Business Intelligence

The worldwide map and table tracks NON-US offices, fabrics, competitors and subsidiaries.

Worldwide · Competitors Table

Sourced from FMP or manual.

Competitor	Source	Accuracy	Country	City
Madrigal Pharmaceuticals, Inc.	FMP	High	United States	West Conshohocken
Apellis Pharmaceuticals, Inc.	FMP	High	United States	Waltham
IVERIC bio, Inc.	FMP	High	United States	Parsippany
Akero Therapeutics, Inc.	FMP	High	United States	South San Francisco
Blueprint Medicines Corporation	FMP	High	United States	Cambridge
Karuna Therapeutics, Inc.	FMP	High	United States	Boston

Worldwide · Subsidiaries Table

Sourced from the SEC, through government awards and manual entries.

Subsidiary	Private?	Country	City
-	-	-	-